Head and Neck Oncology
Head and Neck Oncology
批准号:
8300279
负责人:
MAX S. WICHA
金额:
$8.31万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2017-05-31
关键词:
AccountingAddressAffectAgeBasic ScienceBehavior TherapyBehavioral ResearchBioinformaticsBiological MarkersBiological PreservationCancer CenterCancer Center Support GrantCancer PatientCancer cell lineCandidate Disease GeneCarcinogenesis MechanismCellsCetuximabCharacteristicsCisplatinClinicClinical ResearchClinical TrialsCollaborationsComorbidityCorrelative StudyDiagnosisDietDirect CostsDiseaseFacultyFundingFutureGene ExpressionGoalsGrantHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and neck structureHealth behaviorHuman PapillomavirusHuman papillomavirus 16IL6 geneImmune systemImmunobiologyImmunotherapeutic agentIn complete remissionInterventionInvestigationJointsKnowledgeLaboratoriesLaboratory StudyLaryngectomyLasersMalignant NeoplasmsMalignant neoplasm of larynxMetastatic Squamous Cell CarcinomaMetastatic/RecurrentMethylationMichiganModalityMolecularMolecular BiologyMolecular ProfilingMorbidity - disease rateNeoplasm MetastasisOrgan PreservationOutcomeOutcome MeasureOutcome StudyPaperPatientsPharmaceutical PreparationsPhasePopulation ResearchPreventionPrevention programPrimary PreventionPublishingQualifyingQuality of lifeRandomizedRecurrenceRehabilitation therapyResearchResearch PersonnelResistanceRiskRoboticsRoleSchoolsSecondary Cancer PreventionSerumSmokeSmokerSupplementationTechniquesTestingTherapeuticTranslatingTranslational ResearchTreatment FailureTumor Suppressor GenesTumor stageUniversitiesUniversity HospitalsUniversity of Michigan Comprehensive Cancer Centeranticancer researchbasecancer recurrencecancer stem cellchemotherapycytokinedesigndocetaxelevidence baseexperiencefundamental researchhead and neck cancer patientimprovedinhibitor/antagonistmalignant oropharynx neoplasmmembermind body interactionmultidisciplinaryneoplastic cellnon-smokernon-smokingnoveloncologyoncology programoutcome forecastprogramsprotein expressionreconstructionsmall moleculesmoking cessationsoy protein isolatesurvivorshiptreatment responsetumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Head and Neck Oncology Program (HNOP) is a comprehensive program in head and neck cancer research that includes a multidisciplinary team of Investigators In basic, clinical, behavioral, population and translational research. The program consists of 44 members from 11 departments in five schools across the University of Michigan. The HNOP's direct cost funding has increased by 60% over this grant period, to over $5 million of which $2 is in NCI funding, including a Head and Neck SPORE. Program members published 293 papers during this grant period, 22.5% of which demonstrated intra-programmatic and 33.4% Inter-programmatic collaborations. Many members of this program also hold joint membership in other Cancer Center basic science or prevention programs which integrate additional fundamental research into the underlying mechanisms of head and neck cancer behavior and treatment.
The major research themes of the HNOP are to;
1. Identify mechanisms of carcinogenesis and progression
2. Determine the molecular determinants of treatment response
3. Characterize the immunobiology of the tumor microenvironment to better modulate the immune system as a therapeutic modality
4. Characterize the role of cancer stem cells in tumor progression, Invasion, metastasis and resistance to treatment
5. Define new treatment combinations based on laboratory and clinical studies that define new biomarkers for individualized therapies
6. Define organ preservation strategies in head and neck cancer
7. Develop and implement novel reconstruction and rehabilitation techniques for head and neck cancer patients
This program has undergone considerable recruitment over this grant period with 18 new faculty members, and a renewed/expanded emphasis on translational research that should become fully realized over the next grant cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting breast cancer stem cells
-
批准号:10331012
-
项目类别:
-
资助金额:$91.14万
-
财政年份:2016
-
负责人:MAX S. WICHA
-
依托单位:
Targeting breast cancer stem cells
-
批准号:8955932
-
项目类别:
-
资助金额:$93.0万
-
财政年份:2016
-
负责人:MAX S. WICHA
-
依托单位:
Targeting breast cancer stem cells
-
批准号:10093979
-
项目类别:
-
资助金额:$91.55万
-
财政年份:2016
-
负责人:MAX S. WICHA
-
依托单位:
Cancer Cell Biology
-
批准号:8709427
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2013
-
负责人:MAX S. WICHA
-
依托单位:
Cancer Cell Biology
-
批准号:8719610
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:MAX S. WICHA
-
依托单位:
Experimental Therapeutics
-
批准号:8300274
-
项目类别:
-
资助金额:$54.07万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Cancer Genetics
-
批准号:8300271
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Flow Cytometry
-
批准号:8300287
-
项目类别:
-
资助金额:$13.98万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Prostate Oncology
-
批准号:8300276
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
High Throughput Screening
-
批准号:8300297
-
项目类别:
-
资助金额:$12.51万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Gastrointestinal Oncology
-
批准号:8300280
-
项目类别:
-
资助金额:$16.91万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Biomedical Prevention
-
批准号:8300282
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Immunologic Monitoring
-
批准号:8300291
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Socio-Behavioral
-
批准号:8300283
-
项目类别:
-
资助金额:$14.22万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Patient and Population Sciences
-
批准号:8300285
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Molecular Imaging
-
批准号:8300273
-
项目类别:
-
资助金额:$4.96万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Hematologic Malignancies/BMT
-
批准号:8300281
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Cancer Informatics
-
批准号:8300284
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Pharmacokinetics
-
批准号:8300292
-
项目类别:
-
资助金额:$15.44万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
Tissue and Molecular Pathology
-
批准号:8300290
-
项目类别:
-
资助金额:$14.79万
-
财政年份:2012
-
负责人:MAX S. WICHA
-
依托单位:
海外基金